<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34756671</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-9133</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>6 Pt 1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title><ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation></Journal><ArticleTitle>The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan.</ArticleTitle><Pagination><StartPage>1101</StartPage><EndPage>1107</EndPage><MedlinePgn>1101-1107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2021.09.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1684-1182(21)00205-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enhanced nonpharmaceutical interventions (NPIs) to prevent the Coronavirus Disease 2019 (COVID-19) have shown various levels of impact on common respiratory pathogens. We aimed to analyze the epidemiological changes seen in certain common respiratory viruses found in Taiwanese children (e.g., influenza virus, enterovirus, parainfluenza virus, adenovirus and respiratory syncytial virus (RSV)) after the implementation of public health measures, as well as interpret the possible meaning of these changes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective observational study examined the viral isolation from children younger than 18 years at a medical center in central Taiwan during the period January 2015-December 2020, a time frame of six years. Viral isolations prior to the COVID-19 pandemic (January 2015-December 2019), along with those during the post-COVID-19 period (January-December 2020) were analyzed and compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6899 throat swab samples were collected during the pre-pandemic period of 2015-2019, with 2681 of them having a positive result (38.86%). There were a total of 713 samples collected in 2020, with 142 of them showing positive results (19.92%). The overall positive rate of viral isolates significantly decreased in 2020 (p &lt; 0.001). Declines in the isolation of the influenza virus, parainfluenza virus, adenovirus and enterovirus were observed. The RSV surprisingly became the leading isolate, with up to 47 (6.59%) instances in 2020, and showing an unusual peak in the winter of 2020. The rise began in September of 2020 and reached its plateau in November of that year.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most respiratory viruses decreased under NPIs regarding SARS-CoV-2. However, the RSV outbreak in the winter of 2020 had shown the limitation of current NPIs. Possible explanations have been discussed in details and public preventive measures should be reinforced for RSV, particularly amongst people having young children both at home and in care centers.</AbstractText><CopyrightInformation>Copyright © 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Hao-Ting</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Section of Pediatric Infectious Disease, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fang-Liang</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Section of Pediatric Infectious Disease, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ting</LastName><ForeName>Pei-Ju</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Section of Pediatric Infectious Disease, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chun-Chih</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Pathology &amp; Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Po-Yen</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Section of Pediatric Infectious Disease, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan. Electronic address: pychen@vghtc.gov.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Microbiol Immunol Infect</MedlineTA><NlmUniqueID>100956211</NlmUniqueID><ISSNLinking>1684-1182</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="Y">Paramyxoviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Influenza virus</Keyword><Keyword MajorTopicYN="N">Non-pharmaceutical intervention</Keyword><Keyword MajorTopicYN="N">Respiratory syncytial virus</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare there are no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>14</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34756671</ArticleId><ArticleId IdType="pmc">PMC8501510</ArticleId><ArticleId IdType="doi">10.1016/j.jmii.2021.09.017</ArticleId><ArticleId IdType="pii">S1684-1182(21)00205-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cowling B.J., Aiello A.E. Public health measures to slow community spread of Coronavirus disease 2019. J Infect Dis. 2020;221(11):1749–1751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184488</ArticleId><ArticleId IdType="pubmed">32193550</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster Y., Michael-Gayego A., Rivkin M., Levinson L., Wolf D.G., Nir-Paz R. Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? Clin Microbiol Infect. 2021;27:811–812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833997</ArticleId><ArticleId IdType="pubmed">33352303</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Lee H., Song K.H., Kim E.S., Park J.S., Jung J., et al. Impact of public health interventions on seasonal influenza activity during the SARS-CoV-2 outbreak in Korea. Clin Infect Dis. 2021;73(1):132–140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314207</ArticleId><ArticleId IdType="pubmed">32472687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto H., Ishikane M., Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. J Am Med Assoc. 2020;323(19):1969–1971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149351</ArticleId><ArticleId IdType="pubmed">32275293</ArticleId></ArticleIdList></Reference><Reference><Citation>Angoulvant F., Ouldali N., Yang D.D., Filser M., Gajdos V., Rybak A., et al. COVID-19 pandemic: impact caused by school closure and national lockdown on pediatric visits and admissions for viral and non-viral infections, a time series analysis. Clin Infect Dis. 2021;72(2):319–322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314162</ArticleId><ArticleId IdType="pubmed">33501967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I., Artama M., Makela L., Backman K., Heiskanen-Kosma T., Renko M. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J. 2020;39(12):e423–e427.</Citation><ArticleIdList><ArticleId IdType="pubmed">32773660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen L.D., Seeman S., Bruden D., Klejka J., Desnoyers C., Tiesinga J., et al. Impact of social distancing and travel restrictions on non-COVID-19 respiratory hospital admissions in young children in rural Alaska. Clin Infect Dis. 2021;72(12):2196–2198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499549</ArticleId><ArticleId IdType="pubmed">32888007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J.Y., Conceicao E.P., Sim X.Y.J., Wee L.E.I., Aung M.K., Venkatachalam I. Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections. J Hosp Infect. 2020;106(2):387–389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384982</ArticleId><ArticleId IdType="pubmed">32730772</ArticleId></ArticleIdList></Reference><Reference><Citation>Worby C.J., Chang H.H. Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic. Nat Commun. 2020;11(1):4049. doi: 10.1038/s41467-020-17922-x. www.nature.com/naturecommunications</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17922-x</ArticleId><ArticleId IdType="pmc">PMC7426871</ArticleId><ArticleId IdType="pubmed">32792562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson T., Del Mar C., Dooley L., Ferroni E., Al-Ansary L.A., Bawazeer G.A., et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. Br Med J. 2009;339:b3675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749164</ArticleId><ArticleId IdType="pubmed">19773323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.H., Lin S.H. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis. 2020;26(10):2509–2511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510692</ArticleId><ArticleId IdType="pubmed">32730735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A.P., Chu I.Y., Yeh M.L., Chen Y.Y., Lee C.L., Lin H.H., et al. Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: hospital-based retrospective observational study in Taiwan. Influenza Other Respir Viruses. 2021;15(4):478–487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189242</ArticleId><ArticleId IdType="pubmed">33825310</ArticleId></ArticleIdList></Reference><Reference><Citation>National infectious surveillance system. https://nidss.cdc.gov.tw/Home/Index?op=2</Citation></Reference><Reference><Citation>Patrozou E., Mermel L.A. Does influenza transmission occur from asymptomatic infection or prior to symptom onset? Publ Health Rep. 2009;124(2):193–196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646474</ArticleId><ArticleId IdType="pubmed">19320359</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A.E., Murray G.F., Perez V., Coulborn R.M., Davis B.M., Uddin M., et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis. 2010;201(4):491–498.</Citation><ArticleIdList><ArticleId IdType="pubmed">20088690</ArticleId></ArticleIdList></Reference><Reference><Citation>Suess T., Remschmidt C., Schink S.B., Schweiger B., Nitsche A., Schroeder K., et al. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011. BMC Infect Dis. 2012;12:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285078</ArticleId><ArticleId IdType="pubmed">22280120</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger R., Morita H., Comito D., Filip I., Galanti M., Lane B., et al. Asymptomatic shedding of respiratory virus among an ambulatory population across seasons. mSphere. 2018;3(4):1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041500</ArticleId><ArticleId IdType="pubmed">29997120</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanti M., Birger R., Ud-Dean M., Filip I., Morita H., Comito D., et al. Rates of asymptomatic respiratory virus infection across age groups. Epidemiol Infect. 2019;147(e176):1–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6518513</ArticleId><ArticleId IdType="pubmed">31063096</ArticleId></ArticleIdList></Reference><Reference><Citation>Munywoki P.K., Koech D.C., Agoti C.N., Bett A., Cane P.A., Medley G.F., et al. Frequent asymptomatic respiratory syncytial virus infections during an epidemic in a rural Kenyan household cohort. J Infect Dis. 2015;212(11):1711–1718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4633757</ArticleId><ArticleId IdType="pubmed">25941331</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao M.M.A., Apostol L.N., de Quiroz-Castro M., Jee Y., Roque V., Jr., Mapue M., 2nd, et al. Non-polio enteroviruses among healthy children in the Philippines. BMC Publ Health. 2020;20:167–172. doi: 10.1186/s12889-020-8284-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-8284-x</ArticleId><ArticleId IdType="pmc">PMC6998086</ArticleId><ArticleId IdType="pubmed">32013921</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton P.N., Hu N., Saravanos G., Shrapnel J., Davis J., Snelling T., et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020;4(11):e42–e43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500894</ArticleId><ArticleId IdType="pubmed">32956616</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan W.Y., Thoon K.C., Loo L.H., Chan K.S., Oon L.L.E., Ramasamy A., et al. Trends in respiratory virus infections during the COVID-19 pandemic in Singapore, 2020. JAMA Netw Open. 2021;4(6):e2115973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239970</ArticleId><ArticleId IdType="pubmed">34181015</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H., Chang I.S., Tsai F.Y., Huang L.M., Shao P.L., Chiu N.C., et al. Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007. J Formos Med Assoc. 2011;110(6):388–396.</Citation><ArticleIdList><ArticleId IdType="pubmed">21741007</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner H.C., Anderson L.J., Pickering L.K. Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab. Pediatrics. 2004;114(4):1082–1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">15466107</ArticleId></ArticleIdList></Reference><Reference><Citation>Loscertales M.P., Roca A., Ventura P.J., Abacassamo F., Dos Santos F., Sitaube M., et al. Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr Infect Dis J. 2002;21(2):148–155.</Citation><ArticleIdList><ArticleId IdType="pubmed">11840083</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensballe L.G., Devasundaram J.K., Simoes E.A. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003;22(2 Suppl):S21–S32.</Citation><ArticleIdList><ArticleId IdType="pubmed">12671449</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchers A.T., Chang C., Gershwin M.E., Gershwin L.J. Respiratory syncytial virus–a comprehensive review. Clin Rev Allergy Immunol. 2013;45(3):331–379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090643</ArticleId><ArticleId IdType="pubmed">23575961</ArticleId></ArticleIdList></Reference><Reference><Citation>Handforth J., Friedland J.S., Sharland M. Basic epidemiology and immunopathology of RSV in children. Paediatr Respir Rev. 2000;1(3):210–214.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan D., Biswasroy P., Kumar Naik P., Ghosh G., Rath G. A review of current interventions for COVID-19 prevention. Arch Med Res. 2020;51(5):363–374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190516</ArticleId><ArticleId IdType="pubmed">32409144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.W., Huang Y.C., Ho T.H., Huang C.G., Tsao K.C., Lin T.Y. Viral etiology of bronchiolitis among pediatric inpatients in northern Taiwan with emphasis on newly identified respiratory viruses. J Microbiol Immunol Infect. 2014;47(2):116–121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105232</ArticleId><ArticleId IdType="pubmed">23040235</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13(3):371–384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88938</ArticleId><ArticleId IdType="pubmed">10885982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>